Replies to post #110749 on Biotech Values

[DewDiligence]

I've never seen any compiled data per se, but it appears that smaller is better. In all essence isn't that what Novartis is doing? While NVS still has a huge RD budget it really has formed an independent network of mini research centers all over the world…

No, jbog. NVS has a few large in-house research centers including the main one in Cambridge, Massachusetts. What NVS is doing with basic reserach is the polar opposite of what you’re suggesting for PFE.

[DewDiligence]

When I think of what large drugs PFE came out with over the past decade I come up with Sutent (purchased), Chantix (mistake) and Lyrica. Those drugs aren't worth $50 billion.

What does the $50B figure refer to? There’s no argument that PFE’s R&D has produced poor results in the past decade, but does it necessarily follow that outsourcing basic research from here on will lead to an improvement? Perhaps a better fix is to hire smarter scientists (#msg-16127025).